MENU
+Compare
PHVS
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$24.25
Change
-$1.56 (-6.04%)
Capitalization
1.66B

PHVS Pharvaris NV Forecast, Technical & Fundamental Analysis

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks... Show more

PHVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PHVS with price predictions
Nov 12, 2025

PHVS in upward trend: price rose above 50-day moving average on November 11, 2025

PHVS moved above its 50-day moving average on November 11, 2025 date and that indicates a change from a downward trend to an upward trend. In of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on PHVS as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PHVS just turned positive on November 11, 2025. Looking at past instances where PHVS's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PHVS advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for PHVS crossed bearishly below the 50-day moving average on October 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PHVS broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PHVS entered a downward trend on October 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.585) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.723).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PHVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PHVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PHVS is expected to report earnings to fall 22.70% to -64 cents per share on April 14

Pharvaris NV PHVS Stock Earnings Reports
Q4'25
Est.
$-0.64
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.08
Q3'24
Missed
by $0.18
The last earnings report on August 12 showed earnings per share of -82 cents, missing the estimate of -76 cents. With 109.00K shares outstanding, the current market capitalization sits at 1.66B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Emmy Noetherweg 2
Phone
+31 712036410
Employees
65
Web
https://www.pharvaris.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHVX48.810.59
+1.22%
Hartford Healthcare R6
NBRTX28.570.11
+0.39%
Neuberger Berman M/C Intrinsic Val Inst
JMVZX33.590.06
+0.18%
JPMorgan Mid Cap Value R2
PSBPX31.91-0.01
-0.03%
Principal SmallCap R5
AMCZX18.45-0.05
-0.27%
Alger Mid Cap Growth Z

PHVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with INKT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
+7.01%
INKT - PHVS
35%
Loosely correlated
+0.15%
NUVL - PHVS
33%
Poorly correlated
+0.91%
CELC - PHVS
30%
Poorly correlated
+7.56%
HOWL - PHVS
30%
Poorly correlated
-3.54%
MGTX - PHVS
30%
Poorly correlated
-2.70%
More